Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622851 · ClinicalTrials.gov registry record · NA
Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05622851: Completed NA study, sponsored by Galderma R&D.
NCT05622851 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05622851, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
To assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound
Primary Outcome
Investigator visually reviewed ultrasound scans to determine filler flexibility and aggregation once injected into skin tissues.
Interventions
- DEVICE Restylane Contour
- DEVICE Juvederm Voluma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2023-12-06 |
| Phase | NA |
What the finished NCT05622851 record still lists
NCT05622851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Restylane Contour is the first listed.
NCT05622851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05622851 about?
NCT05622851 is a clinical study titled "Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers". To assess and compare tissue aggregation and visualization of two Hyaluronic Acid fillers via ultrasound
What is the current status of trial NCT05622851?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2022-07-12. Estimated completion is 2023-12-06.
What interventions are being tested in trial NCT05622851?
The interventions under investigation include: Restylane Contour (DEVICE), Juvederm Voluma (DEVICE).
Who is sponsoring clinical trial NCT05622851?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05622851's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI